Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oommen John

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Kidney International Reports|November 9, 2019
Study to Test and Operationalize Preventive Approaches for CKD of Undetermined Etiology in Andhra Pradesh, IndiaOommen John, Balaji Gummidi, Abha Tewari, et al.
Cancer Investigation|November 1, 2023
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast CancerAshish Singh, Josh Thomas Georgy, Anjana Joel, et al.
The New England Journal of Medicine|April 16, 2015
A randomized, controlled trial of an aerosolized vaccine against measlesNicola Low, Ashish Bavdekar, Lakshmanan Jeyaseelan, et al.
Kidney International Reports|November 22, 2021
Chronic Kidney Disease of Unknown Etiology in India: What Do We Know and Where We Need to GoOommen John, Balaji Gummudi, Anubhuti Jha, et al.
JCO Global Oncology|March 24, 2025
Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched AnalysisPraveen Kumar Marimuthu, Josh Thomas Georgy, Deepa Susan Joy Philip, et al.
BMJ Open|June 1, 2022
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from IndiaBharath Kumar Tirupakuzhi Vijayaraghavan, Vivekanand Jha, Dorrilyn Rajbhandari, et al.
European Journal of Human Genetics : EJHG|March 28, 2024
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South IndiansAjoy Oommen John, Ashish Singh, Pratibha Yadav, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trialPraveen Kumar Marimuthu, Chitra Renukaradhya, Shalini Sahu, et al.
South Asian Journal of Cancer|December 22, 2025
Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi MethodAnant Ramaswamy, Sujay Srinivas, Viraj Lavingia, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Kidney International Reports|November 9, 2019
Study to Test and Operationalize Preventive Approaches for CKD of Undetermined Etiology in Andhra Pradesh, IndiaOommen John, Balaji Gummidi, Abha Tewari, et al.
Cancer Investigation|November 1, 2023
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast CancerAshish Singh, Josh Thomas Georgy, Anjana Joel, et al.
The New England Journal of Medicine|April 16, 2015
A randomized, controlled trial of an aerosolized vaccine against measlesNicola Low, Ashish Bavdekar, Lakshmanan Jeyaseelan, et al.
Kidney International Reports|November 22, 2021
Chronic Kidney Disease of Unknown Etiology in India: What Do We Know and Where We Need to GoOommen John, Balaji Gummudi, Anubhuti Jha, et al.
JCO Global Oncology|March 24, 2025
Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched AnalysisPraveen Kumar Marimuthu, Josh Thomas Georgy, Deepa Susan Joy Philip, et al.
BMJ Open|June 1, 2022
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from IndiaBharath Kumar Tirupakuzhi Vijayaraghavan, Vivekanand Jha, Dorrilyn Rajbhandari, et al.
European Journal of Human Genetics : EJHG|March 28, 2024
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South IndiansAjoy Oommen John, Ashish Singh, Pratibha Yadav, et al.
The Lancet Regional Health. Southeast Asia|March 11, 2026
Low-dose nivolumab with neoadjuvant chemotherapy and oral metronomic therapy in borderline resectable oral cavity squamous cell carcinoma: a phase II trialPraveen Kumar Marimuthu, Chitra Renukaradhya, Shalini Sahu, et al.
South Asian Journal of Cancer|December 22, 2025
Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi MethodAnant Ramaswamy, Sujay Srinivas, Viraj Lavingia, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Pageof 7